Depression News

Pediatric behavioral health company Elemy has announced centralized diagnosis-to-treatment services to provide faster clinical support and comprehensive care for children suffering from behavioral, emotional and developmental disorders.

ATLANTA — In patients who recently developed gestational diabetes, addressing stress and associated postpartum depressive symptoms early may reduce the risk for developing type 2 diabetes, researchers said.

Peer worker–facilitated psychiatric advance directives proved effective in decreasing compulsory hospital admissions and increasing certain positive outcomes for those with mental illness, according to a study published in JAMA Psychiatry.

NEW ORLEANS – Patients who received cariprazine in addition to their standard antidepressant showed clinical improvement for depression, Gary Sachs, MD, said at the American Psychiatric Association annual meeting.

NEW ORLEANS — Risks for depression and suicidal ideation are higher among people with vs. without diabetes, and cases of suicide are likely underreported, according to a presenter at the American Diabetes Association Scientific Sessions.

Zuranolone, an investigational oral drug for treating postpartum depression in women, met its primary and secondary endpoints in a phase 3 trial, Sage Therapeutics and Biogen announced in a release.

NEW ORLEANS – The American Psychiatric Association DSM steering committee gathered at the APA annual meeting to review proposed changes to the manual, committee chair Paul S. Appelbaum, MD, said.

NEW ORLEANS – A number of new treatments are on the horizon for PTSD, making the future bright for patients with this condition, Charles B. Nemeroff, MD, PhD, said at the American Psychiatric Association annual meeting.

NEW ORLEANS – Decreased work hours, more treatment, and better sleep and shift length can help address the high rate of depression among training physicians, according to a speaker at the American Psychiatric Association annual meeting.

Depression is associated with a six-fold increased risk for mortality in patients with incident rheumatoid arthritis, according to data presented at the EULAR 2022 Congress.